Verastem Statistics
Total Valuation
Verastem has a market cap or net worth of $285.19 million. The enterprise value is $244.41 million.
Important Dates
The next estimated earnings date is Thursday, August 7, 2025, after market close.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Verastem has 54.95 million shares outstanding. The number of shares has increased by 73.09% in one year.
| Current Share Class | 54.95M |
| Shares Outstanding | 54.95M |
| Shares Change (YoY) | +73.09% |
| Shares Change (QoQ) | +11.22% |
| Owned by Insiders (%) | 0.74% |
| Owned by Institutions (%) | 62.16% |
| Float | 42.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 22.08 |
| Forward PS | 6.30 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 24.44 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.50
| Current Ratio | 3.50 |
| Quick Ratio | 3.31 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -36.17 |
Financial Efficiency
Return on equity (ROE) is -2,159.52% and return on invested capital (ROIC) is -114.52%.
| Return on Equity (ROE) | -2,159.52% |
| Return on Assets (ROA) | -64.19% |
| Return on Invested Capital (ROIC) | -114.52% |
| Return on Capital Employed (ROCE) | -136.42% |
| Revenue Per Employee | $128,205 |
| Profits Per Employee | -$1.91M |
| Employee Count | 78 |
| Asset Turnover | 0.08 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Verastem has paid $185,000 in taxes.
| Income Tax | 185,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +49.57% in the last 52 weeks. The beta is 0.85, so Verastem's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | +49.57% |
| 50-Day Moving Average | 6.60 |
| 200-Day Moving Average | 5.16 |
| Relative Strength Index (RSI) | 33.06 |
| Average Volume (20 Days) | 2,316,096 |
Short Selling Information
The latest short interest is 13.18 million, so 23.98% of the outstanding shares have been sold short.
| Short Interest | 13.18M |
| Short Previous Month | 13.28M |
| Short % of Shares Out | 23.98% |
| Short % of Float | 30.90% |
| Short Ratio (days to cover) | 6.49 |
Income Statement
In the last 12 months, Verastem had revenue of $10.00 million and -$148.88 million in losses. Loss per share was -$3.50.
| Revenue | 10.00M |
| Gross Profit | 10.00M |
| Operating Income | -131.07M |
| Pretax Income | -89.49M |
| Net Income | -148.88M |
| EBITDA | -131.04M |
| EBIT | -131.07M |
| Loss Per Share | -$3.50 |
Full Income StatementBalance Sheet
The company has $117.57 million in cash and $76.80 million in debt, giving a net cash position of $40.77 million or $0.74 per share.
| Cash & Cash Equivalents | 117.57M |
| Total Debt | 76.80M |
| Net Cash | 40.77M |
| Net Cash Per Share | $0.74 |
| Equity (Book Value) | -32.43M |
| Book Value Per Share | -0.63 |
| Working Capital | 89.08M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$115.14 million and capital expenditures -$7,000, giving a free cash flow of -$115.15 million.
| Operating Cash Flow | -115.14M |
| Capital Expenditures | -7,000 |
| Free Cash Flow | -115.15M |
| FCF Per Share | -$2.10 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -1,310.71% |
| Pretax Margin | -1,486.92% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Verastem does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -73.09% |
| Shareholder Yield | -73.09% |
| Earnings Yield | -52.20% |
| FCF Yield | -40.38% |
Analyst Forecast
The average price target for Verastem is $12.71, which is 144.89% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.71 |
| Price Target Difference | 144.89% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 117.78% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 1, 2023. It was a reverse split with a ratio of 0.0833333:1.
| Last Split Date | Jun 1, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.0833333:1 |
Scores
Verastem has an Altman Z-Score of -12.42 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.42 |
| Piotroski F-Score | 1 |